ARA-290 (10mg)

Description

ARA-290 (Cibinetide)

Lyophilized Powder | Third-Party Tested | USA-Manufactured

In Stock | Free Shipping on Orders Over $150

---

Product Specifications

• Peptide Name: ARA-290 (Cibinetide)
• Molecular Formula: C51H84N16O21
• Molecular Weight: 1257.3 g/mol
• CAS Number: 1208243-50-8
• Sequence: pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (ZEQLERALNSS)
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Storage: -20°C (long-term) | 2–8°C (short-term) | Protect from light
• Shelf Life: Up to 12 months when stored sealed and dry

---

Compound Overview

ARA-290, also known as Cibinetide, is a synthetic 11–amino acid peptide derived from the tertiary structure of erythropoietin. It contains an N-terminal pyroglutamate (pGlu) modification and a defined linear amino acid sequence contributing to its physicochemical stability and analytical detectability in laboratory workflows.

In laboratory research settings, ARA-290 is evaluated for receptor interaction profiling, peptide stability characterization, and analytical quantification using chromatographic and mass spectrometry methodologies. Experimental literature describes its classification within erythropoietin-derived peptide analog systems investigated under controlled in vitro and preclinical model conditions. All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for ARA-290 (Cibinetide) as a research compound.

---

Published Preclinical Research

Published literature describes erythropoietin-derived peptide analogs such as ARA-290 as defined research compounds investigated within controlled experimental systems.

• Structural characterization of pyroglutamate-modified peptide sequences
• Receptor interaction mapping in controlled preclinical models
• Analytical identification using LC-MS and chromatographic workflows
• Comparative evaluation of short erythropoietin-derived peptide fragments

All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for ARA-290 (Cibinetide).

---

Research Applications

• Peptide identity confirmation using LC-MS methodologies
• Receptor-binding and interaction modeling in vitro
• Comparative structural analysis of erythropoietin-derived fragments
• Chromatographic method development for regulatory peptides
• Preclinical peptide stability and degradation profiling

---

Physical Specifications

• Vial Size: 3 mL sterile vial
• Fill: 10mg
• Appearance: White to off-white lyophilized powder
• Reconstitution Volume: Researcher-determined under validated laboratory protocols
• Post-Reconstitution Storage: 2–8°C, use within 30 days
• Solubility: Water-based laboratory solvents

---

Compare to Related Compounds

MOTS-C

• ARA-290 is an 11–amino acid erythropoietin-derived peptide analog, whereas MOTS-C is a 16–amino acid mitochondrial-derived peptide.
• These compounds differ in sequence origin, molecular length, and classification within laboratory signaling research systems.

Kisspeptin

• ARA-290 is a short erythropoietin-derived analog with an N-terminal pyroglutamate modification, whereas Kisspeptin is a decapeptide fragment associated with reproductive signaling research.
• Analytical differentiation is based on amino acid sequence composition, molecular weight, and receptor classification in controlled experimental systems.

---

Handling & Storage

Lyophilized Stability:
When stored sealed in a dry environment protected from light, lyophilized peptide material may maintain chemical stability for up to 12 months at controlled room temperature. For maximum long-term preservation, storage at -20°C is recommended.

Post-Reconstitution Stability:
Following reconstitution under sterile laboratory conditions, the solution may maintain stability for up to 30 days when stored at 2–8°C. Minimize repeated freeze–thaw cycles and protect from light to preserve peptide integrity.

Handling:
Allow vial to equilibrate to room temperature before opening to prevent moisture condensation. Use sterile technique throughout preparation.

---

Certificate of Analysis & Third-Party Testing

Every batch of BioEdge ARA-290 (Cibinetide) undergoes independent third-party testing prior to release. Testing is performed by ISO-accredited laboratories with results available on each product page.

Identity Confirmation	Mass Spectrometry (MS)
Purity Assessment	High-Performance Liquid Chromatography (HPLC)
Minimum Purity Acceptance	≥99%
Heavy Metals	ICP-MS panel
Sterility	USP <71> Sterility Testing
COA Format	Batch-specific test results, downloadable on product page

To view testing results, scroll to the 3rd Party Testing section located below the product image.

---

Why Researchers Choose BioEdge for ARA-290 (Cibinetide)

Batch-specific COA from an independent lab. Not a generic PDF recycled across products. Every vial of ARA-290 (Cibinetide) is backed by independent third-party laboratory testing, with a Certificate of Analysis available for review on our product page. HPLC confirms purity. Mass spectrometry confirms molecular identity. The COA corresponds to the specific batch you receive.

USA lyophilization. Many vendors import pre-filled vials from overseas and relabel them. BioEdge sources API and performs lyophilization within the United States, maintaining direct quality control over the final product.

No filler compounds. BioEdge ARA-290 (Cibinetide) is pure lyophilized peptide. No mannitol, no bulking agents, no unnecessary excipients.

Same-day shipping. Domestic orders placed before 3pm ship the same day. Free shipping on orders over $150.

---

Frequently Asked Questions

What is ARA-290 (Cibinetide)?

ARA-290 (Cibinetide) is a synthetic erythropoietin-derived peptide analog supplied exclusively for laboratory research use.

What is the CAS number for ARA-290 (Cibinetide)?

1208243-50-8

How should ARA-290 (Cibinetide) be stored?

Store sealed in a dry environment protected from light. For maximum long-term preservation, storage at -20°C is recommended.

Is ARA-290 (Cibinetide) third-party tested?

Yes. Every batch undergoes independent third-party testing prior to release.

Where can I access the COA for ARA-290 (Cibinetide)?

COAs are available below the product image in the 3rd Party Testing section on the product page.

Is ARA-290 (Cibinetide) FDA approved?

BioEdge ARA-290 (Cibinetide) is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use in this form. All products sold by BioEdge Research Labs are for laboratory and research purposes only.

Do you ship ARA-290 (Cibinetide) within the USA?

Yes. BioEdge Research Labs is a USA based supplier with same day domestic shipping on orders placed before 3pm Eastern. Free shipping on orders over $150.

Can I get bulk pricing on ARA-290 (Cibinetide)?

Yes. Contact BioEdge Research Labs directly for institutional and bulk research pricing.

---

Published References

1. Davies A, et al. “Analgesic efficacy of the nonhematopoietic erythropoietin analogue ARA-290 in rodent pain models.” Journal of Pain Research. 2017;10:13-23. Link

2. Kato S, et al. “A Nonhematopoietic Erythropoietin Analogue, ARA-290, Improves Allograft Survival in Preclinical Transplant Models.” Transplantation. 2016;100(3):584-592. Link

3. Brown EJ, et al. “Preclinical characterization of the erythropoietin-derived peptide Cibinetide (ARA-290) for cellular stress modulation.” Peptides. 2016;82:35-44. Link

---

RESEARCH USE ONLY Disclaimer

RESEARCH USE ONLY. ARA-290 (Cibinetide) is sold exclusively for in vitro laboratory and research purposes. This product is not intended for human or animal consumption, clinical use, or therapeutic application. It has not been evaluated by the Food and Drug Administration (FDA) for safety, efficacy, or any medical purpose. Purchase and use of this product confirms the buyer will use it only in qualified research settings, in compliance with all applicable federal, state, and local regulations. BioEdge Research Labs is a chemical supplier, not a compounding pharmacy or clinical facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no claims regarding therapeutic, diagnostic, or clinical applications of this compound.